Lykos Therapeutics, formerly MAPS PBC, is dedicated to transforming mental health care through the development of novel therapies and therapeutic approaches to treat mental health conditions, with a focus on evidence-based development of psychedelic-assisted therapies.
Market
Psychedelic-assisted therapies
Location
San Jose,
CA,
USA
Coinvestors
Alexandra Cohen Foundation, Bail Capital, Eir Therapeutics, Helena, Joe and Sandy Samberg Foundation, Satori Neuro, True Ventures, Unlikely Collaborators Foundation, Vine Ventures